Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dividend wake up news failed miserabley

Agreed - Patriot is not for your typical dividend investor.  I don't even want to speculate why Patriot is really paying dividends.  However, I do think they are currently holding back their PR machine and they will give them the go ahead at a strategically predetermined point in time.  (This is my theory because why on earth would they bring on the likes of Hoffman and not utlize them?)

Hopefully, these and other questions will be addressed/answered at the SHM.

Share
New Message
Please login to post a reply